» Articles » PMID: 37676656

The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019

Overview
Journal JAMA Oncol
Specialty Oncology
Date 2023 Sep 7
PMID 37676656
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is crucial for effective policy planning.

Objective: To analyze the total and risk-attributable burden of lip and oral cavity cancer (LOC) and other pharyngeal cancer (OPC) for 204 countries and territories and by Socio-demographic Index (SDI) using 2019 Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates.

Evidence Review: The incidence, mortality, and disability-adjusted life years (DALYs) due to LOC and OPC from 1990 to 2019 were estimated using GBD 2019 methods. The GBD 2019 comparative risk assessment framework was used to estimate the proportion of deaths and DALYs for LOC and OPC attributable to smoking, tobacco, and alcohol consumption in 2019.

Findings: In 2019, 370 000 (95% uncertainty interval [UI], 338 000-401 000) cases and 199 000 (95% UI, 181 000-217 000) deaths for LOC and 167 000 (95% UI, 153 000-180 000) cases and 114 000 (95% UI, 103 000-126 000) deaths for OPC were estimated to occur globally, contributing 5.5 million (95% UI, 5.0-6.0 million) and 3.2 million (95% UI, 2.9-3.6 million) DALYs, respectively. From 1990 to 2019, low-middle and low SDI regions consistently showed the highest age-standardized mortality rates due to LOC and OPC, while the high SDI strata exhibited age-standardized incidence rates decreasing for LOC and increasing for OPC. Globally in 2019, smoking had the greatest contribution to risk-attributable OPC deaths for both sexes (55.8% [95% UI, 49.2%-62.0%] of all OPC deaths in male individuals and 17.4% [95% UI, 13.8%-21.2%] of all OPC deaths in female individuals). Smoking and alcohol both contributed to substantial LOC deaths globally among male individuals (42.3% [95% UI, 35.2%-48.6%] and 40.2% [95% UI, 33.3%-46.8%] of all risk-attributable cancer deaths, respectively), while chewing tobacco contributed to the greatest attributable LOC deaths among female individuals (27.6% [95% UI, 21.5%-33.8%]), driven by high risk-attributable burden in South and Southeast Asia.

Conclusions And Relevance: In this systematic analysis, disparities in LOC and OPC burden existed across the SDI spectrum, and a considerable percentage of burden was attributable to tobacco and alcohol use. These estimates can contribute to an understanding of the distribution and disparities in LOC and OPC burden globally and support cancer control planning efforts.

Citing Articles

Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications.

Ibrahim S, Khan M, Khurram I, Ghani M, Sharifi-Rad J, Calina D Eur J Med Res. 2025; 30(1):169.

PMID: 40082963 PMC: 11907871. DOI: 10.1186/s40001-025-02401-0.


Global, regional, and national mortality of larynx cancer from 1990 to 2021: results from the global burden of disease study.

Han D, Lee H, Oung Q, Lee C World J Surg Oncol. 2025; 23(1):76.

PMID: 40055712 PMC: 11887237. DOI: 10.1186/s12957-025-03720-6.


Epidemiological trends and age-period-cohort effects on lip and oral cavity cancer burden across the BRICS from 1992 to 2021.

Yu Z, Wu Y, Cao Y, Cheng P Front Oncol. 2025; 15:1539417.

PMID: 40034600 PMC: 11873103. DOI: 10.3389/fonc.2025.1539417.


Lip and oral cavity cancer in Iran from 1990 to 2019 based on the global burden of disease study.

Roghanizadeh L, Atarbashi-Moghadam S, Masaebi F, Baghban A Sci Rep. 2025; 15(1):7389.

PMID: 40032973 PMC: 11876645. DOI: 10.1038/s41598-025-92090-w.


Trends in Human Papillomavirus-Related Health Burden in Greece from 1996 to 2021 with a Focus on Cervical and Lip, Oral Cavity, and Pharyngeal Cancer.

Tampakoudis G, Anastasiou O Pathogens. 2025; 14(2).

PMID: 40005573 PMC: 11858740. DOI: 10.3390/pathogens14020197.